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Background: Haemodialysis is a form of renal replacement therapy used to treat
patients with end stage renal failure. It is becoming more appreciated that
haemodialysis patients exhibit higher rates of multiple end organ damage
compared to the general population. There is also a strong emerging evidence that
haemodialysis itself causes circulatory stress. We aimed at examining
haemodynamic patterns during haemodialysis using a new model and test that
model against a normal control.
Methods: We hypothesised that blood pressures generated by each heart beat
constantly vary between local peaks and troughs (local extrema), the frequency and
amplitude of which is regulated to maintain optimal organ perfusion. We also
hypothesised that such model could reveal multiple haemodynamic aberrations
during HD. Using a non-invasive cardiac output monitoring device (Finometer®) we
compared various haemodynamic parameters using the above model between a
haemodialysis patient during a dialysis session and an exercised normal control after
comparison at rest.
Results: Measurements yielded 29,751 data points for each haemodynamic
parameter. Extrema points frequency of mean arterial blood pressure was higher in
the HD subject compared to the normal control (0.761Hz IQR 0.5-0.818 vs 0.468Hz
IQR 0.223-0.872, P < 0.0001). Similarly, extrema points frequency of systolic blood
pressure was significantly higher in haemodialysis compared to normal. In contrary,
the frequency of extrema points for TPR was higher in the normal control compared
to HD (0.947 IQR 0.520-1.512 vs 0.845 IQR 0.730-1.569, P < 0.0001) with significantly
higher amplitudes.
Conclusion: Haemodialysis patients potentially exhibit an aberrant haemodynamic
behaviour characterised by higher extrema frequencies of mean arterial blood
pressure and lower extrema frequencies of total peripheral resistance. This, in
theory, could lead to higher variation in organ perfusion and may be detrimental to
vulnerable vascular beds.
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Patients with end stage renal failure (ESRF) require renal replacement therapy (RRT).
Haemodialysis (HD) is a form of RRT in which the blood is pumped from the patient
into an extracorporeal circuit through an array of semipermeable membranes called the
dialyser. The blood in the dialyser is separated from a fluid called the dialysate by a© 2013 Eldehni et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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dialysate due to diffusion of the molecules according to their concentration gradients.
Traditionally the treatment is given in three sessions a week each session lasting for three
to four hours.
It is becoming more appreciated that HD patients exhibit higher rates of multiple
end organ damage compared to the general population. HD patients for example have
hugely elevated cardiovascular mortality which is estimated to be at least thirty times
greater than aged matched population [1]. There is strong emerging evidence that HD
in itself causes circulatory stress [2]. Many haemodynamic anomalies have been de-
scribed during the HD process. Hypotensive episodes during haemodialysis compli-
cate 20-30% of treatments [3,4]. These intradialytic hypotensive episodes were found
to be predictors of mortality in HD patients [5,6]. Furthermore, regional myocardial
hypoperfusion during haemodialysis causing regional wall motion abnormality
(RWMA) has been demonstrated using both echocardiographic and perfusion scan-
ning methods [7-9].
There are multiple factors that contribute to this abnormal cardiovascular function
and complicate the HD treatment. On macrovascular level, vascular calcification is
predominant in HD patients [10]. This results in increased arterial stiffness and
reduces the ischaemic threshold in this population [11]. On microvascular level,
endothelial dysfunction was evident in ex vivo experiments using wire myography
[12] and laser Doppler imaging [13]. Furthermore, HD patients have higher rates of
autonomic dysfunction expressed in studies as a reduction in baroreflex sensitivity
(BRS) [14-16]. Intact BRS is essential for the regulation of blood pressure by activat-
ing compensatory mechanisms which keep the blood pressure within a narrow
range [15].
All the above factors result in abnormal haemodynamic behaviour during HD that
has not been fully characterised or correlated to measures of end organ damage. We
aimed at examining the haemodynamic pattern during HD and at rest using a
new model and test that model against a normal control.Materials and methods
The haemodynamic model and its validation
Each heart beat generates a pressure pulsation expressed as systolic and diastolic
pressures. These are largely dictated by the stroke volume and the compliance of the
arterial tree. It is this compliance and distensability that lead to the damping of the
pulse pressure in smaller arteries allowing tissue blood flow to be continuous
throughout diastole [17]. From that point of view, perfusion pressure that is gener-
ated by each heart beat is expressed as the mean arterial blood pressure (MAP) [18].
MAP is not the arithmetic average of the systolic and diastolic pressures and is calcu-
lated in clinical practice as
MAP ¼ PDia þ PSys−PDia3 ð1Þ
The body uses several mechanisms such as local chemical and autonomic feedbackto keep the perfusion pressure within the limits that are best for organ viability. We
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tween local peaks and troughs (local extrema), the frequency and amplitude of which
is regulated to maintain optimal organ perfusion. We also hypothesised that such
model could reveal multiple haemodynamic aberrations in HD patients.
When measuring blood pressure by oscillometry using an inflatable cuff to occlude
the brachial artery the measured systolic and diastolic pressures belong each to dif-
ferent heart beats. Hence, the use of such method would not provide sufficient reso-
lution and the use of a continuous beat to beat cardiovascular monitoring device is
needed to examine the above hypothesis.
The Finometer (Finapres Medical Systems, Arnhem, The Netherlands) is a tool for
blood pressure and haemodynamic monitoring. It is particularly useful due to its
non-invasive nature and ability to provide continuous readings over a period of sev-
eral hours. The Finometer works by continuous pulse-wave analysis at the digital ar-
tery and utilises the finger-clamp method, in which changes in digital arterial
diameter are detected by means of an infrared photoplethysmograph [19] and op-
posed by an ultra-fast pressure servo controller that changes pressure in an inflatable
air bladder, both mounted in a finger cuff. This generates an arterial waveform that is
measured on a beat-to-beat basis and is used to reconstruct a central aortic wave-
form by a validated transfer function [20]. This allows calculation of a full range of
haemodynamic variables on a continuous basis; these include pulse rate (HR), mean
arterial blood pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure
(DBP), stroke volume (SV), and total peripheral resistance (TPR).
Ethical approval was obtained from Nottingham research ethics committee (09/
H0408/71).
Using the Finometer we recorded the above haemodynamic parameters in a HD
patient and compared them with those of a healthy volunteer. The data was first
recorded at rest for a period of 25 minutes for the HD patient and 30 minutes for the
normal control (NC). Then the data was collected during a three hours HD session
for the HD patient and to mimic the circulatory stress, the data for the healthy vol-
unteer was collected during exercise using a cycling pedal for a similar period to the
HD session. This yielded a total of 29,751 data points for each haemodynamic par-
ameter measured between the two subjects for analysis.
The analysis of each haemodynamic parameter was done by identifying the local
extrema points then calculating their frequencies and amplitudes using Matlab and
Simulink (R2011a, MathWorks®, Natik, MA, USA). At first local extrema points were
defined (local maxima and local minima). For the points (P) to qualify as an extrema
it has to be either larger than both of its neighbouring points (maxima) or smaller
than neighbouring points (minima) Figure 1.
PMaxima ¼ Pn−1 < Pn > Pnþ1 ð2Þ
PMinima ¼ Pn−1 > Pn < Pnþ1 ð3Þ
The extrema indices were also used to enable pairing with their time points (t).
This was then used to calculate the time elapsed between each consecutive extrema.
t ¼ tExtrema þ 1 − tExtrema ð4Þ
Figure 1 A 30 seconds sample demonstrating extrema points of Mean Arterial Blood Pressure
(MAP) in a haemodialysis patient during haemodialysis (HD) and in a normal control (NC)
during exercise.
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F ¼ 1=t ð5Þ
Finally, the amplitude (a) between two consecutive extrema points was also computeda ¼ aExtremaþ1 − aExtrema ð6Þ
Computational implementation and statistical analysis
Computational implementation of the model was performed using Matlab and
Simulink (R2011a, MathWorks®, Natik, MA, USA). Statistical analysis was performed
using SPSS version 19 (IBM® SPSS Statistics, Inc.). An alpha error at 0.05 was judged
to be significant. All continuous variables were tested for normality using their histo-
grams and normality tests. Parametric data are presented by mean and standard de-
viation (SD), while non-parametric are presented as median and interquartile range
(IQR). Between group differences were tested using the Independent T test or Mann
U Whitney test depending on normality. Correlations were examined by a two-tailed
Pearson test for parametric data and Spearman test for nonparametric data.
Results
Characteristics of both HD and NC subjects are demonstrated in Table 1.
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Extrema points frequency of MAP was higher in HD compared to that of NC in the resting
state (0.781 Hz IQR 0.515-0.813 vs 0.337 Hz IQR 0.172-0.736, P < 0.0001). The same was
noted for SBP and DBP as demonstrated in Table 2. The frequency of extrema points for
TPR was lower in NC (0.787 Hz IQR 0.414-1.55 vs 0.829 Hz IQR 0.588-1.597, P < 0.0001)
but with much higher amplitude (0.113MU IQR 0.039-0.239 vs 0.018MU IQR 0.01-0.031,
P < 0.0001). Cardiac output extrema points frequency demonstrated the same pattern
being higher in HD compared to NC at rest (0.804 Hz IQR 0.749-1.560 vs 0.786 Hz IQR
0.498-1.526).Stress data
Table 3 demonstrates the frequencies and amplitudes of all measured haemodynamic pa-
rameters during HD for the dialysis patient and during exercise for the NC. The frequency
of change between extrema points of MAP was higher in the HD subject compared to the
normal control (0.761 Hz IQR 0.5-0.818 vs 0.468 Hz IQR 0.223-0.872, P < 0.0001). These
were independent of heart rate (r = 0.002, P = 0.887 for HD and r = 0.022, P = 0.290 for
normal control). Similarly, extrema points frequency of systolic blood pressure was signifi-
cantly higher in HD compared to NC (0.772 Hz IQR 0.541-0.840 vs 0.532 Hz IQR 0.331-
0.851, P <0.0001) and so was cardiac output (0.80 Hz IQR 0.737-1.526 vs 0.786 HZ IQR
0.498-1.526, P < 0.0001). However, the frequency of the change between extrema points
for TPR was higher in the normal control compared to HD (0.947 IQR 0.520-1.512 vs
0.845 IQR 0.730-1.569, P < 0.0001) with higher amplitudes (0.049MU IQR 0.022-0.106 vs
0.022MU IRQ 0.012-0.044, P < 0.0001) (Table 3).
On comparison with the resting data, circulatory stress seems to cause a large increase
in the frequency of TPR extrema points in NC to a level that is higher than that of the
HD subject (0.787 Hz IQR 0.414-1.55 vs 0.947Hz IQR 0.52-1.512, P < 0.0001). A similar
but modest response in the frequency of TPR extrema points is noted in HD (0.829 Hz
IRQ 0.588-1.597 vs 0.845 Hz IQR0.739-1.569, P = 0.023). Although there was an increase
in the MAP extrema frequency when exercising in the NC (0.337 Hz IQR 0.172-0.736 vs
0.468 Hz IQR 0.223-0.872, P = 0.009) the frequency remains much lower than the HD pa-
tient which did not demonstrate a significant increase in the MAP extrema frequency dur-
ing dialysis (0.781 Hz IQR 0.0515-0.813 vs 0.761 Hz IQR 0.5-0.818, P = 0.05).Table 1 Characteristics of normal control (NC) and haemodialysis (HD) subjects
HD NC
Age 68 37
Gender Female Male
Diabetes Status Type II Diabetes Mellitus None Diabetic
Cardiovascular disease Stroke None
Blood Pressure (mmHg) 121/75 118/78
Haemodialysis Vintage (days) 152 N/A
Ultrafiltration Volume (mls) 450 N/A
Blood Flow (mls/min) 400 N/A
Type of Vascular Access Left Brachiocephalic Fistula N/A
Table 2 The frequency and amplitude of various haemodynamic parameters between haemodialysis (HD) patient and a normal control (NC) at rest
MAP SBP DBP TPR SV
HD NC P HD NC P HD NC P HD NC P HD NC P
Frequency 0.781 0.337 <0.0001 0.788 0.419 <0.0001 0.763 0.508 0.002 0.829 0.787 <0.0001 0.793 0.727 <0.0001
(0.0515-0.813 (0.172-0.736) (0.536-0.821) (0.234-0.795) (0.401-0.818) (0.239-1.518) (0.588-1.597) (0.414-1.55) (0.539-1.493) (0.391-1.470)
Amplitude 5(3–6) 7(3–12) <0.0001 8(6–10) 8(4–14) 0.549 3(2–4) 5(2–10.75) <0.0001 0.018
(0.01-0.031)
0.113
(0.039-0.239)
<0.0001 10(6–13) 7(4–11) <0.0001
Frequency (Hz), MAP (Mean Arterial Blood Pressure, mmHg), SBP (Systolic Blood Pressure, mmHg), DBP (Diastolic Blood Pressure, mmHg), TPR (Total Peripheral Resistance, MU), SV (Stroke Volume, ml).
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Table 3 The frequency and amplitude of various haemodynamic parameters between haemodialysis (HD) patient and a normal control (NC) during circulatory
stress
MAP SBP DBP TPR SV
HD NC P HD NC P HD NC P HD NC P HD NC P
Frequency 0.761 0.468 <0.0001 0.772 0.532 <0.0001 0.766 0.777 0.052 0.845 0.947 <0.0001 0.78 0.743 <0.0001
(0.5-0.818) (0.223-0.872) (0.541-0.840) (0.331-0.851) (0.403-1.477) (0.311-1.479) (0.739-1.569) (0.52-1.512) (0.565-1.470) (0.478-1.41)
Amplitude 4(3–6) 5 (2–9) <0.0001 7 (3–11) 7 (5–10) <0.0001 3 (2–50) 4 (2–8) <0.0001 0.022
(0.012-0.044)
0.049
(0.022-0.106)
<0.0001 10 (6–15) 9 (6–13) <0.0001
Frequency (Hz), MAP (Mean Arterial Blood Pressure, mmHg), SBP (Systolic Blood Pressure, mmHg), DBP (Diastolic Blood Pressure, mmHg), TPR (Total Peripheral Resistance, MU), SV (Stroke Volume, ml).
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In this proof of concept study we propose the use of frequencies and amplitudes of ex-
trema points to analyse various haemodynamic parameters during HD. Testing the
model during HD against an exercised normal control and at rest revealed multiple ab-
normalities in the haemodynamic behaviour of the HD subject. Firstly, we found that
in the resting state the frequency of extrema points for MAP, SBP and DBP was higher
in HD compared to NC. On the other hand, TPR extrema points frequency at rest was
lower in NC but with higher amplitudes. As a response to circulatory stress the NC
subject seems to have the ability to increase the frequency of TPR extrema points and
maintain a much lower extrema frequency of MAP than the HD subject. This quicker
change in TPR with higher amplitudes would in theory provide a better control and
stability of blood pressure in the NC and the lack of this process in HD subject could
be representative of autonomic dysfunction. HD patients as previously demonstrated
have reduced baroreflex sensitivity which correlates with higher vascular calcification
scores and increased arterial stiffness [14-16,21] and this could explain the differences
between the two subjects at rest. However, the pattern of the haemodynamic response
to circulatory stress seems to be less pronounced in HD compared to NC.
As MAP is considered the perfusion pressure for organs; in the HD subject the vari-
ation of MAP over one minute is higher than that of the normal volunteer. According
to Ohm’s law the pressure difference between two ends of a vessel (P1, P2) is one of the
determinants of blood flow
Q ¼ ΔPð Þ
R
ð6Þ
ΔP ¼ P1−P2 ð7Þ
Therefore, a higher variation in P1 and a lower variation in resistance (R) in theorywould results in higher variation in blood flow to that organ, assuming that the venous
pressure P2 is constant. Hence, in theory HD patients can experience a higher variation
per minute in blood flow compared to normal exercised healthy volunteer. This haemo-
dynamic behaviour could theoretically be detrimental to vulnerable vascular beds.
Previous studies that analysed haemodynamic parameters during HD used periodic
averaging methodologies [22-24]. In the general population, other methods such as
blood pressure variability using standard deviation or averaging the absolute values be-
tween adjacent readings have also been used [25,26]. Spectral analysis of blood pressure
using Fast Fourier Transform formulae treats blood pressure readings as a signal and
identifies the frequencies comprising it and their amplitudes [27]. Cowley et al. 1973
used distribution curves to demonstrate how blood pressure became very variable in
baroreceptor-denervated dogs and was no longer maintained within a narrow range es-
pecially when stimulating the dogs [28].
We have shown using this model a marked difference in the haemodynamic behav-
iour at rest and in response to circulatory stress between the HD and the exercised NC
subjects. The determinants of this haemodynamic behaviour in HD patients are still to
be explored. Although these differences in haemodynamic performance could be attrib-
uted to differences in age and cardiovascular comorbidities between the two subjects; it
is important to demonstrate the model’s ability to detect differences from two ends of
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and lower extrema frequencies of TPR during HD produces higher variability in organ
perfusion; which could contribute to its damage is still to be tested. Studies that correl-
ate between this haemodynamic model and measures of structural and functional organ
damage are currently being undertaken.
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